Share Price and Basic Stock Data
Last Updated: October 9, 2025, 8:55 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Emkay Taps & Cutting Tools Ltd operates in the engineering sector, focusing on the manufacturing of precision tools. As of the latest updates, the company’s share price stands at ₹144, with a market capitalization of ₹154 Cr. Over the years, Emkay has demonstrated a robust growth trajectory in sales, which increased from ₹30 Cr in March 2014 to ₹89 Cr in March 2023. This growth is projected to reach ₹103 Cr by March 2024, highlighting a compound annual growth rate (CAGR) of approximately 25% over the last decade. However, a notable dip is expected in March 2025, with projected sales dropping to ₹42 Cr, indicating potential challenges ahead in sustaining growth.
Profitability and Efficiency Metrics
Despite the impressive sales growth, Emkay Taps & Cutting Tools has been grappling with profitability issues, reflected in its operating profit margin (OPM), which has fluctuated significantly. Currently, the OPM is at -4%, a stark contrast to the highs of 53% in September 2022. The net profit for March 2023 was ₹44 Cr, with a projected increase to ₹72 Cr by March 2024; however, estimates for March 2025 suggest a potential net loss of ₹27 Cr. The company’s return on equity (ROE) and return on capital employed (ROCE) stand at 36% and 35%, respectively, which are impressive compared to the industry averages of 15%-20%. The cash conversion cycle (CCC) is notably efficient at just 1 day, indicating strong operational efficiency.
Balance Sheet Strength and Financial Ratios
Emkay’s balance sheet reflects a conservative approach to leverage, with total borrowings of only ₹4 Cr against reserves of ₹277 Cr. This results in a debt-to-equity ratio of 0.02, well below the industry norm of around 0.5, which suggests a low-risk profile. The current ratio of 1.80 and quick ratio of 1.37 further indicate strong liquidity, enabling the company to meet short-term obligations comfortably. Furthermore, the interest coverage ratio (ICR) is an impressive 412.78x, suggesting that earnings are more than sufficient to cover interest expenses, a strong indicator of financial health. The price-to-book value (P/BV) ratio stands at 2.32, indicating that the market values the company at more than twice its book value, which may reflect investor confidence in future growth prospects.
Shareholding Pattern and Investor Confidence
The shareholding structure of Emkay Taps & Cutting Tools reveals a significant promoter stake of 74.99%, indicating strong control by the founding members. The public holds 25.01% of the shares, while there are no foreign institutional investors (FIIs) or domestic institutional investors (DIIs) reported. This concentrated ownership can be a double-edged sword; while it ensures stability and long-term vision, it may also limit market liquidity. The number of shareholders has grown substantially from 92 in September 2019 to 1,140 by March 2025, reflecting increasing retail investor interest. However, the absence of institutional backing may raise concerns about the company’s ability to attract larger investments in the future, which could impact its growth trajectory.
Outlook, Risks, and Final Insight
Looking forward, Emkay Taps & Cutting Tools faces both opportunities and challenges. The projected sales growth to ₹103 Cr in March 2024 is promising, yet the anticipated decline in 2025 raises concerns about market dynamics or operational inefficiencies. The company’s strong balance sheet and operational metrics present a solid foundation for future expansion, particularly if it can improve profitability. However, risks include reliance on a concentrated promoter structure, lack of institutional investment, and potential volatility in market demand for engineering tools. Overall, while Emkay has strengths in financial health and operational efficiency, it must navigate these risks to capitalize on its growth potential in a competitive landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Emkay Taps & Cutting Tools Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| KPT Industries Ltd | 226 Cr. | 665 | 1,335/541 | 17.5 | 201 | 0.45 % | 25.5 % | 22.5 % | 5.00 |
| Miven Machine Tools Ltd | 26.3 Cr. | 87.5 | 112/58.9 | 18.9 | 0.00 % | % | % | 10.0 | |
| Incon Engineers Ltd | 6.58 Cr. | 15.2 | 20.0/9.31 | 0.83 | 0.00 % | 64.2 % | % | 10.0 | |
| Hittco Tools Ltd | 8.35 Cr. | 13.6 | 16.0/10.3 | 5.07 | 0.00 % | 3.21 % | 0.29 % | 10.0 | |
| Harshil Agrotech Ltd | 46.9 Cr. | 0.66 | 19.3/0.63 | 2.93 | 1.62 | 0.00 % | 17.4 % | 16.4 % | 1.00 |
| Industry Average | 3,560.38 Cr | 470.53 | 38.26 | 119.43 | 0.27% | 38.30% | 16.67% | 6.12 |
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27 | 23 | 20 | 36 | 33 | 38 | 45 | 44 | 49 | 55 | 55 | 41 |
| Expenses | 15 | 16 | 13 | 20 | 18 | 19 | 21 | 24 | 25 | 30 | 30 | 43 |
| Operating Profit | 12 | 8 | 6 | 17 | 15 | 19 | 24 | 20 | 24 | 24 | 25 | -1 |
| OPM % | 46% | 34% | 32% | 46% | 46% | 49% | 53% | 45% | 49% | 44% | 46% | -4% |
| Other Income | 1 | 1 | 3 | 7 | 9 | 5 | 3 | 13 | 17 | 28 | 43 | -8 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 |
| Profit before tax | 12 | 7 | 7 | 22 | 23 | 21 | 25 | 31 | 39 | 51 | 67 | -9 |
| Tax % | 29% | 15% | 18% | 18% | 18% | 22% | 24% | 21% | 21% | 19% | 18% | -11% |
| Net Profit | 8 | 6 | 6 | 18 | 19 | 17 | 19 | 25 | 31 | 41 | 55 | -8 |
| EPS in Rs | 7.79 | 5.48 | 5.66 | 16.61 | 17.38 | 15.57 | 18.00 | 23.23 | 28.85 | 38.35 | 51.40 | -7.70 |
Last Updated: August 1, 2025, 9:45 pm
Below is a detailed analysis of the quarterly data for Emkay Taps & Cutting Tools Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 55.00 Cr. (Sep 2024) to 41.00 Cr., marking a decrease of 14.00 Cr..
- For Expenses, as of Mar 2025, the value is 43.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.00 Cr. (Sep 2024) to 43.00 Cr., marking an increase of 13.00 Cr..
- For Operating Profit, as of Mar 2025, the value is -1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 25.00 Cr. (Sep 2024) to -1.00 Cr., marking a decrease of 26.00 Cr..
- For OPM %, as of Mar 2025, the value is -4.00%. The value appears to be declining and may need further review. It has decreased from 46.00% (Sep 2024) to -4.00%, marking a decrease of 50.00%.
- For Other Income, as of Mar 2025, the value is -8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Sep 2024) to -8.00 Cr., marking a decrease of 51.00 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.00 Cr. (Sep 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Mar 2025, the value is -9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Sep 2024) to -9.00 Cr., marking a decrease of 76.00 Cr..
- For Tax %, as of Mar 2025, the value is -11.00%. The value appears to be improving (decreasing) as expected. It has decreased from 18.00% (Sep 2024) to -11.00%, marking a decrease of 29.00%.
- For Net Profit, as of Mar 2025, the value is -8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 55.00 Cr. (Sep 2024) to -8.00 Cr., marking a decrease of 63.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is -7.70. The value appears to be declining and may need further review. It has decreased from 51.40 (Sep 2024) to -7.70, marking a decrease of 59.10.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 5:38 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30 | 44 | 49 | 53 | 56 | 64 | 51 | 56 | 71 | 89 | 103 | 42 |
| Expenses | 18 | 27 | 32 | 34 | 33 | 35 | 30 | 33 | 37 | 45 | 55 | 46 |
| Operating Profit | 11 | 17 | 17 | 19 | 23 | 29 | 20 | 23 | 34 | 43 | 48 | -4 |
| OPM % | 38% | 38% | 34% | 36% | 41% | 45% | 40% | 41% | 48% | 49% | 47% | -10% |
| Other Income | 0 | 2 | 5 | 2 | 6 | -13 | 1 | 9 | 14 | 16 | 45 | 36 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 |
| Profit before tax | 9 | 16 | 19 | 18 | 25 | 13 | 19 | 29 | 44 | 57 | 90 | 31 |
| Tax % | 36% | 34% | 26% | 33% | 22% | 59% | 24% | 18% | 20% | 22% | 20% | 14% |
| Net Profit | 6 | 11 | 14 | 12 | 20 | 5 | 14 | 24 | 35 | 44 | 72 | 27 |
| EPS in Rs | 11.96 | 10.04 | 13.01 | 10.97 | 18.42 | 4.93 | 13.27 | 22.27 | 32.95 | 41.24 | 67.20 | 25.07 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 3% | 10% | 3% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 83.33% | 27.27% | -14.29% | 66.67% | -75.00% | 180.00% | 71.43% | 45.83% | 25.71% | 63.64% | -62.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | -56.06% | -41.56% | 80.95% | -141.67% | 255.00% | -108.57% | -25.60% | -20.12% | 37.92% | -126.14% |
Emkay Taps & Cutting Tools Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -4% |
| 3 Years: | -16% |
| TTM: | -59% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -103% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 45% |
| 3 Years: | 11% |
| 1 Year: | -58% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 10% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 3:30 am
Balance Sheet
Last Updated: June 16, 2025, 12:11 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.85 | 2 | 2 | 2 | 2 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 49 | 56 | 71 | 83 | 102 | 98 | 111 | 135 | 170 | 215 | 288 | 277 |
| Borrowings | 2 | 2 | 2 | 5 | 4 | 3 | 3 | 0 | 3 | 6 | 6 | 4 |
| Other Liabilities | 7 | 7 | 6 | 8 | 10 | 17 | 11 | 13 | 19 | 25 | 32 | 7 |
| Total Liabilities | 58 | 67 | 81 | 97 | 118 | 128 | 136 | 159 | 203 | 257 | 337 | 299 |
| Fixed Assets | 16 | 14 | 16 | 18 | 17 | 17 | 21 | 19 | 19 | 16 | 14 | 2 |
| CWIP | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 24 | 31 | 36 | 49 | 71 | 65 | 78 | 99 | 144 | 187 | 255 | 283 |
| Other Assets | 18 | 22 | 28 | 30 | 30 | 44 | 37 | 41 | 40 | 53 | 69 | 14 |
| Total Assets | 58 | 67 | 81 | 97 | 118 | 128 | 136 | 159 | 203 | 257 | 337 | 299 |
Below is a detailed analysis of the balance sheet data for Emkay Taps & Cutting Tools Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
- For Reserves, as of Mar 2025, the value is 277.00 Cr.. The value appears to be declining and may need further review. It has decreased from 288.00 Cr. (Mar 2024) to 277.00 Cr., marking a decrease of 11.00 Cr..
- For Borrowings, as of Mar 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 6.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 2.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing). It has decreased from 32.00 Cr. (Mar 2024) to 7.00 Cr., marking a decrease of 25.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 299.00 Cr.. The value appears to be improving (decreasing). It has decreased from 337.00 Cr. (Mar 2024) to 299.00 Cr., marking a decrease of 38.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 12.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 283.00 Cr.. The value appears strong and on an upward trend. It has increased from 255.00 Cr. (Mar 2024) to 283.00 Cr., marking an increase of 28.00 Cr..
- For Other Assets, as of Mar 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Mar 2024) to 14.00 Cr., marking a decrease of 55.00 Cr..
- For Total Assets, as of Mar 2025, the value is 299.00 Cr.. The value appears to be declining and may need further review. It has decreased from 337.00 Cr. (Mar 2024) to 299.00 Cr., marking a decrease of 38.00 Cr..
Notably, the Reserves (277.00 Cr.) exceed the Borrowings (4.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 9.00 | 15.00 | 15.00 | 14.00 | 19.00 | 26.00 | 17.00 | 23.00 | 31.00 | 37.00 | 42.00 | -8.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 91 | 79 | 82 | 92 | 99 | 94 | 100 | 117 | 90 | 81 | 84 | 1 |
| Inventory Days | 484 | 612 | 546 | 827 | 605 | 681 | 635 | 194 | 417 | 518 | 350 | 0 |
| Days Payable | 84 | 150 | 81 | 146 | 211 | 173 | 98 | 85 | 157 | 155 | 91 | |
| Cash Conversion Cycle | 491 | 541 | 548 | 773 | 493 | 602 | 637 | 226 | 350 | 443 | 343 | 1 |
| Working Capital Days | 132 | 115 | 144 | 135 | 111 | 141 | 158 | 181 | 93 | 88 | 95 | 12 |
| ROCE % | 19% | 30% | 29% | 22% | 27% | 12% | 16% | 16% | 19% | 21% | 19% | -0% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 |
|---|---|---|
| FaceValue | 10.00 | 10.00 |
| Basic EPS (Rs.) | 67.38 | 41.35 |
| Diluted EPS (Rs.) | 67.38 | 41.35 |
| Cash EPS (Rs.) | 69.82 | 44.27 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 280.10 | 211.71 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 280.10 | 211.71 |
| Revenue From Operations / Share (Rs.) | 96.94 | 83.04 |
| PBDIT / Share (Rs.) | 87.07 | 56.11 |
| PBIT / Share (Rs.) | 84.62 | 53.19 |
| PBT / Share (Rs.) | 84.41 | 53.06 |
| Net Profit / Share (Rs.) | 67.38 | 41.35 |
| NP After MI And SOA / Share (Rs.) | 67.38 | 41.35 |
| PBDIT Margin (%) | 89.81 | 67.56 |
| PBIT Margin (%) | 87.29 | 64.05 |
| PBT Margin (%) | 87.07 | 63.89 |
| Net Profit Margin (%) | 69.50 | 49.79 |
| NP After MI And SOA Margin (%) | 69.50 | 49.79 |
| Return on Networth / Equity (%) | 24.05 | 19.53 |
| Return on Capital Employeed (%) | 30.15 | 25.01 |
| Return On Assets (%) | 21.30 | 17.18 |
| Total Debt / Equity (X) | 0.02 | 0.02 |
| Current Ratio (X) | 1.80 | 1.76 |
| Quick Ratio (X) | 1.37 | 1.19 |
| Interest Coverage Ratio (X) | 412.78 | 419.60 |
| Interest Coverage Ratio (Post Tax) (X) | 320.41 | 310.23 |
| Enterprise Value (Cr.) | 696.36 | 318.17 |
| EV / Net Operating Revenue (X) | 6.73 | 3.59 |
| EV / EBITDA (X) | 7.49 | 5.31 |
| MarketCap / Net Operating Revenue (X) | 6.70 | 3.54 |
| Price / BV (X) | 2.32 | 1.39 |
| Price / Net Operating Revenue (X) | 6.70 | 3.54 |
| EarningsYield | 0.10 | 0.14 |
After reviewing the key financial ratios for Emkay Taps & Cutting Tools Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 67.38. This value is within the healthy range. It has increased from 41.35 (Mar 23) to 67.38, marking an increase of 26.03.
- For Diluted EPS (Rs.), as of Mar 24, the value is 67.38. This value is within the healthy range. It has increased from 41.35 (Mar 23) to 67.38, marking an increase of 26.03.
- For Cash EPS (Rs.), as of Mar 24, the value is 69.82. This value is within the healthy range. It has increased from 44.27 (Mar 23) to 69.82, marking an increase of 25.55.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 280.10. It has increased from 211.71 (Mar 23) to 280.10, marking an increase of 68.39.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 280.10. It has increased from 211.71 (Mar 23) to 280.10, marking an increase of 68.39.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 96.94. It has increased from 83.04 (Mar 23) to 96.94, marking an increase of 13.90.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 87.07. This value is within the healthy range. It has increased from 56.11 (Mar 23) to 87.07, marking an increase of 30.96.
- For PBIT / Share (Rs.), as of Mar 24, the value is 84.62. This value is within the healthy range. It has increased from 53.19 (Mar 23) to 84.62, marking an increase of 31.43.
- For PBT / Share (Rs.), as of Mar 24, the value is 84.41. This value is within the healthy range. It has increased from 53.06 (Mar 23) to 84.41, marking an increase of 31.35.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 67.38. This value is within the healthy range. It has increased from 41.35 (Mar 23) to 67.38, marking an increase of 26.03.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 67.38. This value is within the healthy range. It has increased from 41.35 (Mar 23) to 67.38, marking an increase of 26.03.
- For PBDIT Margin (%), as of Mar 24, the value is 89.81. This value is within the healthy range. It has increased from 67.56 (Mar 23) to 89.81, marking an increase of 22.25.
- For PBIT Margin (%), as of Mar 24, the value is 87.29. This value exceeds the healthy maximum of 20. It has increased from 64.05 (Mar 23) to 87.29, marking an increase of 23.24.
- For PBT Margin (%), as of Mar 24, the value is 87.07. This value is within the healthy range. It has increased from 63.89 (Mar 23) to 87.07, marking an increase of 23.18.
- For Net Profit Margin (%), as of Mar 24, the value is 69.50. This value exceeds the healthy maximum of 10. It has increased from 49.79 (Mar 23) to 69.50, marking an increase of 19.71.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 69.50. This value exceeds the healthy maximum of 20. It has increased from 49.79 (Mar 23) to 69.50, marking an increase of 19.71.
- For Return on Networth / Equity (%), as of Mar 24, the value is 24.05. This value is within the healthy range. It has increased from 19.53 (Mar 23) to 24.05, marking an increase of 4.52.
- For Return on Capital Employeed (%), as of Mar 24, the value is 30.15. This value is within the healthy range. It has increased from 25.01 (Mar 23) to 30.15, marking an increase of 5.14.
- For Return On Assets (%), as of Mar 24, the value is 21.30. This value is within the healthy range. It has increased from 17.18 (Mar 23) to 21.30, marking an increase of 4.12.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.02. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.02.
- For Current Ratio (X), as of Mar 24, the value is 1.80. This value is within the healthy range. It has increased from 1.76 (Mar 23) to 1.80, marking an increase of 0.04.
- For Quick Ratio (X), as of Mar 24, the value is 1.37. This value is within the healthy range. It has increased from 1.19 (Mar 23) to 1.37, marking an increase of 0.18.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 412.78. This value is within the healthy range. It has decreased from 419.60 (Mar 23) to 412.78, marking a decrease of 6.82.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 320.41. This value is within the healthy range. It has increased from 310.23 (Mar 23) to 320.41, marking an increase of 10.18.
- For Enterprise Value (Cr.), as of Mar 24, the value is 696.36. It has increased from 318.17 (Mar 23) to 696.36, marking an increase of 378.19.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 6.73. This value exceeds the healthy maximum of 3. It has increased from 3.59 (Mar 23) to 6.73, marking an increase of 3.14.
- For EV / EBITDA (X), as of Mar 24, the value is 7.49. This value is within the healthy range. It has increased from 5.31 (Mar 23) to 7.49, marking an increase of 2.18.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 6.70. This value exceeds the healthy maximum of 3. It has increased from 3.54 (Mar 23) to 6.70, marking an increase of 3.16.
- For Price / BV (X), as of Mar 24, the value is 2.32. This value is within the healthy range. It has increased from 1.39 (Mar 23) to 2.32, marking an increase of 0.93.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 6.70. This value exceeds the healthy maximum of 3. It has increased from 3.54 (Mar 23) to 6.70, marking an increase of 3.16.
- For EarningsYield, as of Mar 24, the value is 0.10. This value is below the healthy minimum of 5. It has decreased from 0.14 (Mar 23) to 0.10, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Emkay Taps & Cutting Tools Ltd:
- Net Profit Margin: 69.5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 30.15% (Industry Average ROCE: 38.3%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 24.05% (Industry Average ROE: 16.67%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 320.41
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.37
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 38.26)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 69.5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Engineering - General | B-27 & B-27/1, M.I.D.C. Industrial Area, Nagpur Maharashtra 440016 | investors@etctl.com http://www.etctl.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ajayprakash Kanoria | Chairman & M.D & CEO |
| Mrs. Alka Kanoria | Whole Time Director |
| Mr. Mahesh Mor | Ind. Non-Executive Director |
| Mr. Ravindra Loiya | Ind. Non-Executive Director |
| Mr. P C Ramchandran | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Emkay Taps & Cutting Tools Ltd?
Emkay Taps & Cutting Tools Ltd's intrinsic value (as of 09 October 2025) is 11.85 which is 91.65% lower the current market price of 142.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹151 Cr. market cap, FY2025-2026 high/low of 606/140, reserves of ₹277 Cr, and liabilities of 299 Cr.
What is the Market Cap of Emkay Taps & Cutting Tools Ltd?
The Market Cap of Emkay Taps & Cutting Tools Ltd is 151 Cr..
What is the current Stock Price of Emkay Taps & Cutting Tools Ltd as on 09 October 2025?
The current stock price of Emkay Taps & Cutting Tools Ltd as on 09 October 2025 is 142.
What is the High / Low of Emkay Taps & Cutting Tools Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Emkay Taps & Cutting Tools Ltd stocks is 606/140.
What is the Stock P/E of Emkay Taps & Cutting Tools Ltd?
The Stock P/E of Emkay Taps & Cutting Tools Ltd is .
What is the Book Value of Emkay Taps & Cutting Tools Ltd?
The Book Value of Emkay Taps & Cutting Tools Ltd is 269.
What is the Dividend Yield of Emkay Taps & Cutting Tools Ltd?
The Dividend Yield of Emkay Taps & Cutting Tools Ltd is 0.00 %.
What is the ROCE of Emkay Taps & Cutting Tools Ltd?
The ROCE of Emkay Taps & Cutting Tools Ltd is 0.35 %.
What is the ROE of Emkay Taps & Cutting Tools Ltd?
The ROE of Emkay Taps & Cutting Tools Ltd is 0.36 %.
What is the Face Value of Emkay Taps & Cutting Tools Ltd?
The Face Value of Emkay Taps & Cutting Tools Ltd is 10.0.